Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Creasey

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Critical Care Medicine|July 11, 2001
Tissue factor pathway inhibitor activity in severe sepsisA A Creasey, K Reinhart
Cancer Research|November 1, 1986
Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factorA A Creasey, M T Reynolds, W Laird
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicityA A Creasey, R Yamamoto, C R Vitt
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1980
Role of G0-G1 arrest in the inhibition of tumor cell growth by interferonA A Creasey, J C Bartholomew, T C Merigan
The Journal of Biological Chemistry|January 25, 1987
Use of a sensitive receptor binding assay to discriminate between full-length and truncated human recombinant tumor necrosis factor proteinsJ A Carlino, L S Lin, A A Creasey
Molecular and Cellular Biology|December 1, 1984
Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cellsE C O'Rourke, R J Drummond, A A Creasey
Blood|June 15, 1997
Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14C T Park, A A Creasey, S D Wright
Critical Care Medicine|February 15, 2001
The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsisS M Opal, J E Palardy, N A Parejo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982
Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell linesT Y Basham, M F Bourgeade, A A Creasey, et al.
The Journal of Experimental Medicine|March 1, 1990
A serum factor that suppresses the cytotoxic function of cytokine-stimulated human eosinophilsD S Silberstein, M S Minkoff, A A Creasey, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Critical Care Medicine|July 11, 2001
Tissue factor pathway inhibitor activity in severe sepsisA A Creasey, K Reinhart
Cancer Research|November 1, 1986
Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factorA A Creasey, M T Reynolds, W Laird
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicityA A Creasey, R Yamamoto, C R Vitt
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1980
Role of G0-G1 arrest in the inhibition of tumor cell growth by interferonA A Creasey, J C Bartholomew, T C Merigan
The Journal of Biological Chemistry|January 25, 1987
Use of a sensitive receptor binding assay to discriminate between full-length and truncated human recombinant tumor necrosis factor proteinsJ A Carlino, L S Lin, A A Creasey
Molecular and Cellular Biology|December 1, 1984
Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cellsE C O'Rourke, R J Drummond, A A Creasey
Blood|June 15, 1997
Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14C T Park, A A Creasey, S D Wright
Critical Care Medicine|February 15, 2001
The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsisS M Opal, J E Palardy, N A Parejo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982
Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell linesT Y Basham, M F Bourgeade, A A Creasey, et al.
The Journal of Experimental Medicine|March 1, 1990
A serum factor that suppresses the cytotoxic function of cytokine-stimulated human eosinophilsD S Silberstein, M S Minkoff, A A Creasey, et al.
Pageof 4